

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.41571462 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.30725628 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30725628 |
| 4 | exogenous drug catabolic process (GO:0042738) | 7.23272024 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.00573553 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.00573553 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.55953341 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51938254 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.28590726 |
| 10 | drug metabolic process (GO:0017144) | 6.24502412 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.91820419 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.91820419 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.91820419 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.79624661 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.69324446 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68822637 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61342532 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.59359380 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.50500137 |
| 20 | urea metabolic process (GO:0019627) | 5.50455237 |
| 21 | urea cycle (GO:0000050) | 5.50455237 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.37825773 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.35143641 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.17650464 |
| 25 | cysteine metabolic process (GO:0006534) | 5.16737882 |
| 26 | protein carboxylation (GO:0018214) | 5.16638892 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.16638892 |
| 28 | alkaloid metabolic process (GO:0009820) | 5.07150243 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.06276487 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.05158069 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.04000591 |
| 32 | bile acid metabolic process (GO:0008206) | 5.03655855 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.01274971 |
| 34 | oxidative demethylation (GO:0070989) | 4.98913617 |
| 35 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.98763979 |
| 36 | negative regulation of sterol transport (GO:0032372) | 4.96233794 |
| 37 | negative regulation of cholesterol transport (GO:0032375) | 4.96233794 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 4.95554151 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.95350479 |
| 40 | phospholipid efflux (GO:0033700) | 4.90202380 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.90104136 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.89942747 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82362816 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.82362816 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.82362816 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.80346514 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80189250 |
| 48 | hormone catabolic process (GO:0042447) | 4.80163274 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.78147053 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.69771455 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.68164691 |
| 52 | regulation of complement activation (GO:0030449) | 4.67108147 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.65357357 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.65357357 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.60839145 |
| 56 | ethanol metabolic process (GO:0006067) | 4.56730513 |
| 57 | angiotensin maturation (GO:0002003) | 4.53811034 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.51936325 |
| 59 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.50183039 |
| 60 | cellular glucuronidation (GO:0052695) | 4.44871618 |
| 61 | intestinal absorption (GO:0050892) | 4.43808080 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 4.43615997 |
| 63 | lysine catabolic process (GO:0006554) | 4.40275829 |
| 64 | lysine metabolic process (GO:0006553) | 4.40275829 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.39366239 |
| 66 | cholesterol efflux (GO:0033344) | 4.33890333 |
| 67 | negative regulation of hemostasis (GO:1900047) | 4.33874726 |
| 68 | negative regulation of blood coagulation (GO:0030195) | 4.33874726 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.21275489 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.21031827 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 4.20436349 |
| 72 | glycine metabolic process (GO:0006544) | 4.20129509 |
| 73 | ethanol oxidation (GO:0006069) | 4.13136240 |
| 74 | drug catabolic process (GO:0042737) | 4.13108100 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.12964193 |
| 76 | negative regulation of coagulation (GO:0050819) | 4.10616794 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.10449807 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.09465304 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.07740186 |
| 80 | amine catabolic process (GO:0009310) | 4.07740186 |
| 81 | glutamate metabolic process (GO:0006536) | 4.06067227 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.06065956 |
| 83 | ketone body metabolic process (GO:1902224) | 4.05029711 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03686627 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.98362474 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.97193217 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.97193217 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.93526799 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.93526799 |
| 90 | complement activation (GO:0006956) | 3.89896739 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86448565 |
| 92 | negative regulation of wound healing (GO:0061045) | 3.86064351 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.85941174 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.85852460 |
| 95 | NADH metabolic process (GO:0006734) | 3.84597263 |
| 96 | intestinal cholesterol absorption (GO:0030299) | 3.83915703 |
| 97 | arginine metabolic process (GO:0006525) | 3.83610109 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.82887621 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.82872316 |
| 100 | fibrinolysis (GO:0042730) | 3.82371486 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.81623004 |
| 102 | aldehyde catabolic process (GO:0046185) | 3.81322197 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 3.81186127 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80337909 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.79979880 |
| 106 | sterol homeostasis (GO:0055092) | 3.79853574 |
| 107 | drug transmembrane transport (GO:0006855) | 3.78830827 |
| 108 | protein-lipid complex assembly (GO:0065005) | 3.77032089 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.76084388 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.72994448 |
| 111 | short-chain fatty acid metabolic process (GO:0046459) | 3.72360775 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.71581776 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.70660017 |
| 114 | fructose metabolic process (GO:0006000) | 3.66345701 |
| 115 | drug transport (GO:0015893) | 3.65074441 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.63214456 |
| 117 | organic acid catabolic process (GO:0016054) | 3.63214456 |
| 118 | response to nitrosative stress (GO:0051409) | 3.60251305 |
| 119 | heme transport (GO:0015886) | 3.59231302 |
| 120 | cofactor catabolic process (GO:0051187) | 3.58325709 |
| 121 | protein activation cascade (GO:0072376) | 3.57244880 |
| 122 | lipoprotein metabolic process (GO:0042157) | 3.57034311 |
| 123 | complement activation, classical pathway (GO:0006958) | 3.56144609 |
| 124 | opsonization (GO:0008228) | 3.55366542 |
| 125 | renal system process involved in regulation of blood volume (GO:0001977) | 3.43187102 |
| 126 | regulation of humoral immune response (GO:0002920) | 3.41752469 |
| 127 | diacylglycerol metabolic process (GO:0046339) | 3.41574912 |
| 128 | xenobiotic metabolic process (GO:0006805) | 3.41398095 |
| 129 | negative regulation of protein activation cascade (GO:2000258) | 3.38936012 |
| 130 | acute-phase response (GO:0006953) | 3.32941080 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.32686494 |
| 132 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.26258051 |
| 133 | protein-lipid complex subunit organization (GO:0071825) | 3.25756554 |
| 134 | arginine catabolic process (GO:0006527) | 3.23282476 |
| 135 | lipoprotein transport (GO:0042953) | 3.09216509 |
| 136 | positive regulation of hemostasis (GO:1900048) | 3.08443320 |
| 137 | positive regulation of blood coagulation (GO:0030194) | 3.08443320 |
| 138 | regulation of guanylate cyclase activity (GO:0031282) | 3.08286422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.26807331 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17423994 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83629476 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41299714 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07449015 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.99549895 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85451216 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99306351 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80925921 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.22203393 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04530990 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6630897 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91891392 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61438508 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56091311 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51560199 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46625535 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45506472 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41756049 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39164531 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37418310 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35667232 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30408368 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27738572 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26091003 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23806848 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22778433 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22168327 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19174859 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16754307 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15060360 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08132320 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00020158 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97084813 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96418152 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94590367 |
| 37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93008369 |
| 38 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90293321 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88893880 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87488117 |
| 41 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87034722 |
| 42 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85069623 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84190505 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82834305 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82096232 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81008657 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80495915 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80311410 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79765395 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79153750 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78682655 |
| 52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78361339 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77996994 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.77399344 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76879101 |
| 56 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76405133 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75969531 |
| 58 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.75917691 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75652811 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75366497 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75069999 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74907042 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74717904 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74404491 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74172026 |
| 66 | NFYA_21822215_ChIP-Seq_K562_Human | 0.73722240 |
| 67 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.72666237 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72565285 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71889194 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71539090 |
| 71 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.70639292 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69545064 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69309072 |
| 74 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68500407 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68313019 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.67397315 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67375843 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67375843 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67372928 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65954861 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65392270 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.65368641 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65308500 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65201923 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64846536 |
| 86 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64476613 |
| 87 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.63507955 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.63240422 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62206600 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62144870 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61683131 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61018556 |
| 93 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60955679 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58619763 |
| 95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57768396 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56879454 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56504527 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55629526 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55463718 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55272885 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54987545 |
| 102 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54777185 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52988129 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52826919 |
| 105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52099844 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51705158 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51596787 |
| 108 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50987734 |
| 109 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49532056 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49384141 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49074561 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.48218511 |
| 113 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.47945049 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.46610547 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45904718 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45874390 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44597639 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43814743 |
| 119 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43743718 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.41435040 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41342928 |
| 122 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41074182 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41015929 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40814141 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40080024 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40006330 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39842277 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38993481 |
| 129 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37938807 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37745793 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37162348 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36679064 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36497387 |
| 134 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36130749 |
| 135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.35307948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.41353894 |
| 2 | MP0005360_urolithiasis | 7.56430095 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39234154 |
| 4 | MP0005365_abnormal_bile_salt | 6.03134283 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.20547652 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.20141080 |
| 7 | MP0003252_abnormal_bile_duct | 3.93084212 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58119881 |
| 9 | MP0009840_abnormal_foam_cell | 3.32220096 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.96544737 |
| 11 | MP0005083_abnormal_biliary_tract | 2.93237343 |
| 12 | MP0003195_calcinosis | 2.62036242 |
| 13 | MP0005332_abnormal_amino_acid | 2.60377121 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38602796 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.23625378 |
| 16 | MP0000609_abnormal_liver_physiology | 2.12766456 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09266031 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00605857 |
| 19 | MP0003868_abnormal_feces_composition | 1.89547410 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.84584991 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.76389812 |
| 22 | MP0001764_abnormal_homeostasis | 1.58167741 |
| 23 | MP0009697_abnormal_copulation | 1.57743239 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51330163 |
| 25 | MP0003011_delayed_dark_adaptation | 1.40022885 |
| 26 | MP0005451_abnormal_body_composition | 1.39716670 |
| 27 | MP0002822_catalepsy | 1.37089552 |
| 28 | MP0004043_abnormal_pH_regulation | 1.28480797 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.26331171 |
| 30 | MP0003879_abnormal_hair_cell | 1.23809588 |
| 31 | MP0000566_synostosis | 1.22905750 |
| 32 | MP0004147_increased_porphyrin_level | 1.20846685 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.19771333 |
| 34 | MP0003866_abnormal_defecation | 1.17544198 |
| 35 | MP0003186_abnormal_redox_activity | 1.15796389 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.14405459 |
| 37 | MP0000598_abnormal_liver_morphology | 1.10811819 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.09616737 |
| 39 | MP0002254_reproductive_system_inflammat | 1.08825668 |
| 40 | MP0005647_abnormal_sex_gland | 1.06534114 |
| 41 | MP0000604_amyloidosis | 1.03975727 |
| 42 | MP0009764_decreased_sensitivity_to | 1.02286999 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.01133272 |
| 44 | MP0001664_abnormal_digestion | 1.00412078 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 0.99755973 |
| 46 | MP0009763_increased_sensitivity_to | 0.95996086 |
| 47 | MP0008469_abnormal_protein_level | 0.85947603 |
| 48 | MP0009642_abnormal_blood_homeostasis | 0.85926553 |
| 49 | MP0005409_darkened_coat_color | 0.85705967 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.85601575 |
| 51 | MP0009379_abnormal_foot_pigmentation | 0.82266533 |
| 52 | MP0000477_abnormal_intestine_morphology | 0.81967371 |
| 53 | MP0001663_abnormal_digestive_system | 0.81438109 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.80504401 |
| 55 | MP0005408_hypopigmentation | 0.79343885 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.78864660 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.76971365 |
| 58 | MP0000462_abnormal_digestive_system | 0.76153170 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.76042285 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 0.75091064 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.73925040 |
| 62 | MP0000538_abnormal_urinary_bladder | 0.71785221 |
| 63 | MP0005334_abnormal_fat_pad | 0.68015126 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 0.67633251 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 0.67573731 |
| 66 | MP0002971_abnormal_brown_adipose | 0.66102945 |
| 67 | MP0009785_altered_susceptibility_to | 0.66018489 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.65612602 |
| 69 | MP0009053_abnormal_anal_canal | 0.64049089 |
| 70 | MP0001661_extended_life_span | 0.63480845 |
| 71 | MP0005266_abnormal_metabolism | 0.60820548 |
| 72 | MP0005670_abnormal_white_adipose | 0.60506166 |
| 73 | MP0004130_abnormal_muscle_cell | 0.60295490 |
| 74 | MP0005448_abnormal_energy_balance | 0.60026518 |
| 75 | MP0003690_abnormal_glial_cell | 0.59486615 |
| 76 | MP0003329_amyloid_beta_deposits | 0.58877184 |
| 77 | MP0001756_abnormal_urination | 0.58865217 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.57926738 |
| 79 | MP0001501_abnormal_sleep_pattern | 0.57185844 |
| 80 | MP0005535_abnormal_body_temperature | 0.56940710 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.56366828 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.52838315 |
| 83 | MP0002168_other_aberrant_phenotype | 0.52700822 |
| 84 | MP0001873_stomach_inflammation | 0.52249278 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.49460304 |
| 86 | MP0000537_abnormal_urethra_morphology | 0.48679019 |
| 87 | MP0003283_abnormal_digestive_organ | 0.48455037 |
| 88 | MP0008873_increased_physiological_sensi | 0.48453560 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.48411572 |
| 90 | MP0003724_increased_susceptibility_to | 0.47827568 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 0.46926919 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.46688649 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.46500614 |
| 94 | MP0000490_abnormal_crypts_of | 0.46264251 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.45792602 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.45030552 |
| 97 | MP0005187_abnormal_penis_morphology | 0.44937653 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.44658257 |
| 99 | MP0006082_CNS_inflammation | 0.44072476 |
| 100 | MP0002796_impaired_skin_barrier | 0.43983605 |
| 101 | MP0005395_other_phenotype | 0.43036841 |
| 102 | MP0003718_maternal_effect | 0.42938691 |
| 103 | MP0002928_abnormal_bile_duct | 0.42914476 |
| 104 | MP0005166_decreased_susceptibility_to | 0.42847485 |
| 105 | MP0003953_abnormal_hormone_level | 0.42635899 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.41542320 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.41391945 |
| 108 | MP0008872_abnormal_physiological_respon | 0.39980855 |
| 109 | MP0008874_decreased_physiological_sensi | 0.37612325 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.37109953 |
| 111 | MP0003075_altered_response_to | 0.36874849 |
| 112 | MP0003436_decreased_susceptibility_to | 0.36868880 |
| 113 | MP0003959_abnormal_lean_body | 0.36110924 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.35260718 |
| 115 | MP0000249_abnormal_blood_vessel | 0.33416415 |
| 116 | MP0009115_abnormal_fat_cell | 0.32917308 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.31985903 |
| 118 | MP0003045_fibrosis | 0.31820829 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.30486131 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.30125693 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.29835254 |
| 122 | MP0002132_abnormal_respiratory_system | 0.29662874 |
| 123 | MP0000579_abnormal_nail_morphology | 0.28414713 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.28306188 |
| 125 | MP0001881_abnormal_mammary_gland | 0.28123074 |
| 126 | MP0004883_abnormal_blood_vessel | 0.27767428 |
| 127 | MP0002060_abnormal_skin_morphology | 0.27000395 |
| 128 | MP0009672_abnormal_birth_weight | 0.26952428 |
| 129 | MP0001243_abnormal_dermal_layer | 0.26498921 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.26262198 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.26165538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.33443182 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.20596868 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14743279 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.69303143 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65729521 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.40149092 |
| 7 | Xanthomatosis (HP:0000991) | 6.22919891 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.49592662 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.92108413 |
| 10 | Complement deficiency (HP:0004431) | 4.92070856 |
| 11 | Hyperammonemia (HP:0001987) | 4.57326642 |
| 12 | Joint hemorrhage (HP:0005261) | 4.56969609 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48791753 |
| 14 | Epidermoid cyst (HP:0200040) | 4.37706936 |
| 15 | Hyperglycinemia (HP:0002154) | 4.34930800 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32782148 |
| 17 | Fat malabsorption (HP:0002630) | 4.31495542 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17049886 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.16861978 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14273607 |
| 21 | Ketosis (HP:0001946) | 4.12668020 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.02325594 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.00155058 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.99226557 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96903691 |
| 26 | Hyperglycinuria (HP:0003108) | 3.91920057 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84332546 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.84332546 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.69689222 |
| 30 | Abnormality of complement system (HP:0005339) | 3.61359110 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61286386 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59685534 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.43906534 |
| 34 | Nephritis (HP:0000123) | 3.38748135 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32184075 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29448173 |
| 37 | Ileus (HP:0002595) | 3.25397548 |
| 38 | Steatorrhea (HP:0002570) | 3.13309959 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10079454 |
| 40 | Spontaneous abortion (HP:0005268) | 3.03304839 |
| 41 | Ketoacidosis (HP:0001993) | 3.01729122 |
| 42 | Malnutrition (HP:0004395) | 2.96936388 |
| 43 | Potter facies (HP:0002009) | 2.96754464 |
| 44 | Facial shape deformation (HP:0011334) | 2.96754464 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.93059327 |
| 46 | Metabolic alkalosis (HP:0200114) | 2.91192601 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.89649922 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.88288118 |
| 49 | Myocardial infarction (HP:0001658) | 2.85819755 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.85276413 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.80451435 |
| 52 | Metabolic acidosis (HP:0001942) | 2.76635978 |
| 53 | Acanthocytosis (HP:0001927) | 2.74961330 |
| 54 | Osteomalacia (HP:0002749) | 2.72394630 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67229117 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.67229117 |
| 57 | Vascular calcification (HP:0004934) | 2.67143331 |
| 58 | Skin nodule (HP:0200036) | 2.65386518 |
| 59 | Hyperactive renin-angiotensin system (HP:0000841) | 2.64770163 |
| 60 | Widely patent fontanelles and sutures (HP:0004492) | 2.64137480 |
| 61 | Lethargy (HP:0001254) | 2.61595745 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.59734126 |
| 63 | Abdominal distention (HP:0003270) | 2.56119443 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.54517935 |
| 65 | Hyperphosphaturia (HP:0003109) | 2.46930625 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.46337284 |
| 67 | Cholecystitis (HP:0001082) | 2.46337284 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.44356486 |
| 69 | Gout (HP:0001997) | 2.43673854 |
| 70 | Glomerulonephritis (HP:0000099) | 2.39522157 |
| 71 | Cholelithiasis (HP:0001081) | 2.39374470 |
| 72 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.38136104 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.36361943 |
| 74 | Late onset (HP:0003584) | 2.35526785 |
| 75 | Spastic diplegia (HP:0001264) | 2.33624230 |
| 76 | Cerebral edema (HP:0002181) | 2.31954927 |
| 77 | Confusion (HP:0001289) | 2.29961467 |
| 78 | Irritability (HP:0000737) | 2.29747715 |
| 79 | Esophageal varix (HP:0002040) | 2.29208600 |
| 80 | Hypophosphatemia (HP:0002148) | 2.28674791 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.28081874 |
| 82 | Mitral stenosis (HP:0001718) | 2.27962605 |
| 83 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25779824 |
| 84 | Gingival bleeding (HP:0000225) | 2.24442564 |
| 85 | Amyloidosis (HP:0011034) | 2.23206129 |
| 86 | Pancreatitis (HP:0001733) | 2.20950776 |
| 87 | Abnormal urine phosphate concentration (HP:0012599) | 2.19974465 |
| 88 | Hyperuricemia (HP:0002149) | 2.18068577 |
| 89 | Increased purine levels (HP:0004368) | 2.18068577 |
| 90 | Nephrolithiasis (HP:0000787) | 2.17832466 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.17649241 |
| 92 | Neonatal onset (HP:0003623) | 2.17522326 |
| 93 | Menorrhagia (HP:0000132) | 2.13846671 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.12865171 |
| 95 | Flat acetabular roof (HP:0003180) | 2.12011998 |
| 96 | Opisthotonus (HP:0002179) | 2.09879732 |
| 97 | Poikilocytosis (HP:0004447) | 2.08888801 |
| 98 | Vomiting (HP:0002013) | 2.08027483 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07909410 |
| 100 | Abnormality of renin-angiotensin system (HP:0000847) | 2.07005659 |
| 101 | Brushfield spots (HP:0001088) | 2.05242766 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.04649904 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04605760 |
| 104 | Chronic diarrhea (HP:0002028) | 2.01700148 |
| 105 | Hemorrhage of the eye (HP:0011885) | 2.01612634 |
| 106 | Enlarged kidneys (HP:0000105) | 1.99733662 |
| 107 | Thrombophlebitis (HP:0004418) | 1.99131382 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.98896608 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 1.98327794 |
| 110 | Rickets (HP:0002748) | 1.97925953 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97305475 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96952380 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.95273207 |
| 114 | Focal segmental glomerulosclerosis (HP:0000097) | 1.94006655 |
| 115 | Abnormality of chloride homeostasis (HP:0011422) | 1.93183692 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.92818751 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.92818751 |
| 118 | Cerebral palsy (HP:0100021) | 1.92328029 |
| 119 | Symptomatic seizures (HP:0011145) | 1.90172155 |
| 120 | Purpura (HP:0000979) | 1.90078376 |
| 121 | Renal tubular acidosis (HP:0001947) | 1.89585617 |
| 122 | Renal cortical cysts (HP:0000803) | 1.88590130 |
| 123 | Fair hair (HP:0002286) | 1.88379156 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.88338386 |
| 125 | Arthropathy (HP:0003040) | 1.87905771 |
| 126 | Alkalosis (HP:0001948) | 1.86237890 |
| 127 | Hypophosphatemic rickets (HP:0004912) | 1.84923252 |
| 128 | Hypokalemia (HP:0002900) | 1.84430637 |
| 129 | Abnormality of urine glucose concentration (HP:0011016) | 1.84131776 |
| 130 | Glycosuria (HP:0003076) | 1.84131776 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83801854 |
| 132 | Proximal tubulopathy (HP:0000114) | 1.83082304 |
| 133 | Protuberant abdomen (HP:0001538) | 1.81836943 |
| 134 | Elevated hepatic transaminases (HP:0002910) | 1.80943923 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.76925560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.46847195 |
| 2 | ACVR1B | 5.42713705 |
| 3 | MST1R | 4.81055276 |
| 4 | FGFR4 | 4.10731816 |
| 5 | SIK1 | 4.07221874 |
| 6 | ERN1 | 4.00731136 |
| 7 | EPHA2 | 3.74422591 |
| 8 | TAOK3 | 3.33596163 |
| 9 | FRK | 2.90025186 |
| 10 | INSRR | 2.70557343 |
| 11 | ERBB4 | 2.35364987 |
| 12 | PKN2 | 2.17826868 |
| 13 | PIK3CA | 2.12161375 |
| 14 | PIK3CG | 2.08263828 |
| 15 | MAP2K4 | 2.04342731 |
| 16 | MET | 1.76240851 |
| 17 | FLT3 | 1.70475763 |
| 18 | PTK6 | 1.65124773 |
| 19 | MAPK11 | 1.63445452 |
| 20 | TYK2 | 1.57606397 |
| 21 | LATS1 | 1.47518567 |
| 22 | DAPK2 | 1.45904307 |
| 23 | STK39 | 1.41058203 |
| 24 | TRIB3 | 1.35505158 |
| 25 | ABL2 | 1.25115311 |
| 26 | KDR | 1.21320582 |
| 27 | FER | 1.18542287 |
| 28 | OXSR1 | 1.17885538 |
| 29 | NEK9 | 1.17818735 |
| 30 | PDK2 | 1.16635835 |
| 31 | PRKAA2 | 1.13428267 |
| 32 | MAP3K11 | 1.11665710 |
| 33 | TAOK1 | 1.10514403 |
| 34 | GRK6 | 1.10371447 |
| 35 | ERBB2 | 1.09253786 |
| 36 | MAP2K2 | 1.09241779 |
| 37 | JAK2 | 1.08360878 |
| 38 | FGFR2 | 1.07318532 |
| 39 | MAP3K7 | 1.07017648 |
| 40 | MAP3K10 | 1.00055980 |
| 41 | NLK | 0.99980355 |
| 42 | BLK | 0.97899183 |
| 43 | TBK1 | 0.95865368 |
| 44 | MAPK15 | 0.95120860 |
| 45 | PRPF4B | 0.93703044 |
| 46 | MAP3K14 | 0.92094916 |
| 47 | TIE1 | 0.91872773 |
| 48 | IRAK3 | 0.91137922 |
| 49 | MAP3K2 | 0.89743448 |
| 50 | MAPK4 | 0.87653322 |
| 51 | JAK1 | 0.86728722 |
| 52 | MAP2K6 | 0.82956833 |
| 53 | EPHB1 | 0.82868206 |
| 54 | PRKCZ | 0.81971053 |
| 55 | MAP2K3 | 0.81873820 |
| 56 | PINK1 | 0.80903060 |
| 57 | CSK | 0.79741235 |
| 58 | PBK | 0.74840517 |
| 59 | MAP3K3 | 0.73625844 |
| 60 | MAP2K1 | 0.72449407 |
| 61 | PRKACG | 0.72171909 |
| 62 | CDK6 | 0.70243400 |
| 63 | STK38L | 0.69398323 |
| 64 | CAMK2G | 0.67897486 |
| 65 | DYRK1B | 0.67774354 |
| 66 | GRK1 | 0.67392466 |
| 67 | CAMK1D | 0.67074012 |
| 68 | RIPK1 | 0.64218057 |
| 69 | MAP3K1 | 0.64175039 |
| 70 | PRKAA1 | 0.63428346 |
| 71 | EPHA3 | 0.61299521 |
| 72 | GSK3A | 0.60864141 |
| 73 | MAP4K1 | 0.60173435 |
| 74 | TESK2 | 0.58990708 |
| 75 | PTK2 | 0.57824753 |
| 76 | NUAK1 | 0.56767769 |
| 77 | MAPK12 | 0.54196080 |
| 78 | KSR2 | 0.53578493 |
| 79 | TNK2 | 0.53415750 |
| 80 | PRKG2 | 0.51483755 |
| 81 | PDPK1 | 0.51111116 |
| 82 | SGK3 | 0.50778424 |
| 83 | MAP3K12 | 0.49841923 |
| 84 | MYLK | 0.49237904 |
| 85 | MATK | 0.48146024 |
| 86 | EPHB2 | 0.47539027 |
| 87 | TNIK | 0.47425100 |
| 88 | PRKG1 | 0.47138359 |
| 89 | RET | 0.44343634 |
| 90 | CASK | 0.44236292 |
| 91 | DDR2 | 0.44087790 |
| 92 | PRKACA | 0.44017176 |
| 93 | PDGFRA | 0.43827197 |
| 94 | IKBKE | 0.43360916 |
| 95 | IGF1R | 0.43306936 |
| 96 | PRKCQ | 0.43157382 |
| 97 | MAPK7 | 0.42667256 |
| 98 | LMTK2 | 0.41656542 |
| 99 | SRC | 0.41386983 |
| 100 | CDC42BPA | 0.40607390 |
| 101 | FGFR3 | 0.39649705 |
| 102 | TGFBR2 | 0.39562287 |
| 103 | RIPK4 | 0.38984502 |
| 104 | ZAP70 | 0.37429557 |
| 105 | MST4 | 0.36524685 |
| 106 | CSNK1G1 | 0.35422992 |
| 107 | MAP3K5 | 0.34526182 |
| 108 | ICK | 0.34153159 |
| 109 | WNK4 | 0.33909276 |
| 110 | BCR | 0.33442915 |
| 111 | PIM2 | 0.33116319 |
| 112 | ADRBK2 | 0.31918444 |
| 113 | CDK4 | 0.31182871 |
| 114 | PRKCA | 0.30789522 |
| 115 | CAMK2D | 0.30258672 |
| 116 | CSF1R | 0.30087609 |
| 117 | PDK1 | 0.28906408 |
| 118 | TAOK2 | 0.28577223 |
| 119 | MAP3K13 | 0.28437067 |
| 120 | YES1 | 0.28140998 |
| 121 | SGK223 | 0.26793875 |
| 122 | SGK494 | 0.26793875 |
| 123 | PRKCI | 0.26185729 |
| 124 | MAPKAPK3 | 0.26101509 |
| 125 | PRKCB | 0.25781864 |
| 126 | SGK1 | 0.25142452 |
| 127 | CSNK1A1 | 0.23943278 |
| 128 | AKT3 | 0.23700629 |
| 129 | EPHA4 | 0.23209743 |
| 130 | SGK2 | 0.23066995 |
| 131 | MTOR | 0.22857544 |
| 132 | PRKCG | 0.22643567 |
| 133 | EGFR | 0.21894462 |
| 134 | IRAK2 | 0.21646632 |
| 135 | CAMK4 | 0.19993451 |
| 136 | PRKACB | 0.16503280 |
| 137 | CAMK1G | 0.16079204 |
| 138 | IRAK1 | 0.15407809 |
| 139 | ABL1 | 0.15003367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28167634 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50167902 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48146805 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06649834 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89293466 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70447963 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66631827 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60604521 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54924341 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50616595 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39078614 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36984569 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34698507 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24048745 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17930765 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02091063 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01314459 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.01172292 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00787840 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91159121 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89880343 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88149511 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87415530 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81813059 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79460126 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.76709551 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73122863 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68387202 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67493590 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63935841 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63197979 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.62779012 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58642691 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49634596 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48458086 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47161513 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45592672 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40295535 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39774490 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37538398 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37288184 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33399465 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33059810 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.26604445 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25270235 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24977777 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17287826 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13956687 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11392724 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10394599 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05070160 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99261389 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96459844 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95563572 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92785844 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90284231 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86799805 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80654295 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.77596216 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77278013 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74593469 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73744510 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73388860 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67973568 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62684923 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53419784 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48794156 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46918586 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46862299 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41847756 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36669965 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34933966 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.27166097 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26743360 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26138864 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22711424 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19825953 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.19643081 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18824529 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18652816 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16542043 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07784651 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.05723910 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03686787 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.02656656 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00639587 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2199782 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2195193 |
| 89 | Pertussis_Homo sapiens_hsa05133 | -0.2103267 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2031906 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1976864 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1909980 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1891739 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | -0.1862678 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1608162 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1525285 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1344203 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1266631 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1247818 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1187336 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1130639 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1106487 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | -0.1077987 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1059954 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | -0.0772252 |
| 106 | Asthma_Homo sapiens_hsa05310 | -0.0649763 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0364048 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0315840 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0284614 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0177251 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0082789 |

